Detalhe da pesquisa
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972026
2.
Latissimus dorsi flap for breast reconstruction: a large single-institution evaluation of surgical outcome and complications.
Arch Gynecol Obstet
; 309(1): 269-280, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584773
3.
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Int J Gynecol Cancer
; 33(7): 1083-1089, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001891
4.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Int J Gynecol Cancer
; 33(2): 223-230, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631151
5.
Primary ovarian leiomyoma: a rare ovarian tumour.
Arch Gynecol Obstet
; 308(4): 1379-1380, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539622
6.
Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer.
Arch Gynecol Obstet
; 306(3): 811-819, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038040
7.
Intraoperative Ultrasound-Guided Excision of Non-Palpable and Palpable Breast Cancer: Systematic Review and Meta-Analysis.
Ultraschall Med
; 43(4): 367-379, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760079
8.
Robotic surgery in gynecology: is the future already here?
Minim Invasive Ther Allied Technol
; 31(6): 815-824, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989636
9.
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 920, 2021 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391399
10.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(5): 699-709, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32305099
11.
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Int J Gynecol Cancer
; 30(7): 920-926, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467335
12.
Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883).
J Med Genet
; 56(9): 574-580, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979843
13.
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.
Gynecol Oncol
; 154(3): 565-570, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227222
14.
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
Ann Surg Oncol
; 24(5): 1314-1321, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27896515
15.
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
BMC Cancer
; 21(1): 1024, 2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526003
16.
Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.
Gynecol Oncol
; 142(3): 465-70, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27184721
17.
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).
Gynecol Oncol
; 140(3): 450-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731724
18.
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).
Int J Gynecol Cancer
; 26(9): 1636-1641, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27654266
19.
The prognostic impact of age in different molecular subtypes of breast cancer.
Breast Cancer Res Treat
; 152(3): 667-73, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26195120
20.
The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study.
Int J Gynecol Cancer
; 25(7): 1248-52, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25978292